A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

(CNN) – The crackdown on off-brand weight loss and diabetes treatment drugs is about to take effect, meaning supplies for the treatments are likely to tighten. A federal deadline to halt sales of the ...

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

Novo Nordisk (NVO) is offering a one-month reduction in the price of its blockbuster weight-loss GLP-1 drug, to help ...

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.